Table 1.
Assessments | Time | |||||||||||
|
Prescreen | Week 1: qualifying period | Week 2: baseline and first week of intervention | Weeks 3-9: intervention | Week 10 | Week 12 | Week 21: 3-month follow-up | Week 24 | Week 33: 6-month follow-up | Week 36 | Week 57: 12-month follow-up | |
Primary outcome | ||||||||||||
|
HbA1ca | Xb | N/Ac | X | N/A | NA/ | X | N/A | X | N/A | X | X |
Secondary outcomes | ||||||||||||
|
Diabetes distress scale | N/A | N/A | X | N/A | X | N/A | X | N/A | X | N/A | X |
|
Measures of Medication Adherence Scale | N/A | N/A | X | N/A | X | N/A | X | N/A | X | N/A | X |
|
Summary of diabetes self-care activities | N/A | N/A | X | N/A | X | N/A | X | N/A | X | N/A | X |
|
Patient Health Questionnaire | X | N/A | X | N/A | X | N/A | X | N/A | X | N/A | X |
|
Positive affect subscale | N/A | N/A | X | N/A | X | N/A | X | N/A | X | N/A | X |
|
Daily assessments | N/A | X | X | X | X | N/A | X | N/A | X | N/A | X |
aHbA1C: hemoglobin A1c.
bX: assessment administered.
cN/A: not applicable.